Press release
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin, 3SBIO
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Global Erythropoietin (EPO) Market Report with TOC: https://goo.gl/PLwvJk
Exogenous erythropoietin can be provided to people whose kidneys cannot make enough. Recombinant human erythropoietin (rhEPO) is produced by recombinant DNA technology in cell culture. Several different pharmaceutical agents are available with a variety of glycosylation patterns and are collectively called erythropoiesis-stimulating agents (ESA). Major examples are epoetin alfa and epoetin beta. The specific details for labeled use vary between the package inserts, but ESAs have been used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Boxed warnings include a risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence. rhEPO has been used illicitly as a performance-enhancing drug; it can often be detected in blood, due to slight differences from the endogenous protein, for example, in features of posttranslational modification.
This report provides detailed analysis of worldwide markets for Erythropoietin (EPO) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Erythropoietin (EPO) market and further lays out an analysis of the factors influencing the supply/demand for Erythropoietin (EPO), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
Global Erythropoietin (EPO) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Erythropoietin (EPO) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies.
Get sample research report at https://goo.gl/wDfqqo
Global Erythropoietin (EPO) Market: key industry players
Amgen (USA)
Johnson & Johnson (USA)
Roche (Switzerland)
Kyowa Hakko Kirin (Japan)
3SBIO
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Erythropoietin (EPO) industry has been provided.
About Market Research Store:
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin, 3SBIO here
News-ID: 484231 • Views: …
More Releases from Market Research Store

Global Building Design and Building Information Modeling (BIM) Software Market D …
The report includes a detailed profile and information of all the major Building Design and Building Information Modeling (BIM) Software market players currently active in the global Building Design and Building Information Modeling (BIM) Software Market. This Building Design and Building Information Modeling (BIM) Software Market Reports aids in the comprehension of the entire market and the identification of growth chances in the worldwide Building Design and Building Information Modeling…

Smart Luggage Market To Witness the Highest Growth Globally in Coming Years 2021 …
Smart Luggage Market
The report for the worldwide Smart Luggage market gives a harsh thought regarding the various factors and patterns influencing the improvement graph of the worldwide market. Advancement of the effect of government strategies and guidelines on the activities in the Smart Luggage market is likewise referenced to offer a comprehensive synopsis of things to come viewpoint of the market. It presents refined development gauges for the Smart Luggage…

Concrete Block and Brick Market Potential Growth, Size, Share, Demand and Analys …
Concrete Block and Brick Market
The report for the worldwide Concrete Block and Brick market gives a harsh thought regarding the various factors and patterns influencing the improvement graph of the worldwide market. Advancement of the effect of government strategies and guidelines on the activities in the Concrete Block and Brick market is likewise referenced to offer a comprehensive synopsis of things to come viewpoint of the market. It presents refined…

Sulfachloropyridazine Sodium Market set size record exponential growth size 2027
Sulfachloropyridazine Sodium Market
The Sulfachloropyridazine Sodium Market report gives an outline of the current market Trend, gradual income, and future viewpoint of the Sulfachloropyridazine Sodium Market.
According to the report, the Global Sulfachloropyridazine Sodium Market is foreseen to observe huge development during the gauge time frame from 2020 to 2027.
The report gives a brief outline and definite bits of knowledge into the market by gathering information from the business specialists…
More Releases for EPO
Erythropoietin (EPO) Treatment Market Outlook and Future Projections for 2030
The erythropoietin (epo) treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Erythropoietin (EPO) Treatment Market, Global Outlook and Forecast 2025-2033
Summary: The Global Erythropoietin (EPO) Treatment Market was valued at US$9242 million in 2022 and is projected to reach US$ 19070 million by 2033, at a CAGR of 6.2% during the forecast period. The Global Erythropoietin (EPO) Treatment Market was valued at US$ 9.24 billion in 2022 and is expected to reach US$ 14.07 billion by 2029, growing at a 6.2% CAGR. EPO is primarily used to treat anemia caused…
Erythropoietin (EPO) Market Analysis & Growth Insights 2024-2033
The Business Research Company recently released a comprehensive report on the Global Erythropoietin (EPO) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
EPO Biomarkers Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global EPO Biomarkers Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…